Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 10Relevant journals,14Conferences,11Workshops are presently dedicated exclusively to breathing disorder and about 268 articles are being published on pulmonary disease.
Pulmonary disease is a lung condition usually caused by smoking that makes it hard to breathe. It is caused by damage to the lungs over many years. Over time, breathing tobacco smoke irritates the airways and destroys the stretchy fibers in the lungs. It affects more than 24 million people in the U.K, or 6 percent of the population. It is the third leading cause of death in the U.K. Other things that may put you at risk include breathing chemical fumes, dust, or air pollution over a long period of time. Secondhand smoke also may damage the lungs. The main symptoms are: A long-lasting (chronic) cough, Mucus that comes up when you cough, Shortness of breath that gets worse when you exercise and excessive sputum production. However, COPD is not just simply a "smoker's cough", but a under-diagnosed, life threatening lung disease that may progressively lead to death. Less common symptoms include anxiety, arm and shoulder pain, and tenderness in the calf of the leg, erythema nodosum, swelling of the face, headache, hoarseness, joint pain, and somnolence.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Pulmonary Disease focusing on concise rapid reporting of clinical studies and reviews in pulmonary disease. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self-management protocols. This journal is directed at specialists and healthcare professionals. Pulmonary disease may lead to various complications such as respiratory failure, right heart failure or cor pulmonale, polyglobulia, and late in the course of the disease, pulmonary hypertension. The course of pulmonary disease is complicated by acute exacerbations that occur with increasing frequency as disease progresses. Pulmonary disease is also associated with extra pulmonary affects. The prevalence of coronary arterial diseases is significantly higher among pulmonary patients compared with individuals of the same age and sex (22% vs. 14.5%). This is also true for cardiac failure (13.5% vs. 2.5%) or neurologic disease (14% vs. 3.5%).
Pulmonary disease is a lung condition usually caused by smoking that makes it hard to breathe. It is caused by damage to the lungs over many years. Over time, breathing tobacco smoke irritates the airways and destroys the stretchy fibers in the lungs. It affects more than 24 million people in the U.S., or 6 percent of the population. It is the third leading cause of death in the U.S. Other things that may put you at risk include breathing chemical fumes, dust, or air pollution over a long period of time. Secondhand smoke also may damage the lungs. The main symptoms are: A long-lasting (chronic) cough, Mucus that comes up when you cough, Shortness of breath that gets worse when you exercise and excessive sputum production. However, COPD is not just simply a "smoker's cough", but a under-diagnosed, life threatening lung disease that may progressively lead to death. Less common symptoms include anxiety, arm and shoulder pain, and tenderness in the calf of the leg, erythema nodosum, swelling of the face, headache, hoarseness, joint pain, and somnolence. Diagnostic procedures for pulmonary diseases include bronchoscopy, cytologic, serologic, and biochemical examination of bronchial secretions; laryngoscopy; pulmonary function tests; and radiography.
Market Analysis:
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd Rhinology and Otology Conference <br>April 25-27, 2016 Dubai, UAE
4th Bacteriology and Infectious Diseases Conference <br>May 16-18, 2016 San Antonio, USA
2nd Respiratory and Pulmonary Medicine Conference <br>May 09-10, 2016 Chicago, USA
3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK
4th Lung and Respiratory Care Conference <br>Aug-1-3, 2016 Manchester, UK
4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA
Infectious Diseases and Diagnostic Microbiology Conference <br>Oct 3-5, 2016 Vancouver, Canada
2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat centers:
GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on April 25, 2024